Copyright Reports & Markets. All rights reserved.

Global Human Thrombin for Extemal Use (Freeze-dried) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 500IU
    • 1.3.3 1000IU
    • 1.3.4 2500IU
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Human Thrombin for Extemal Use (Freeze-dried) Market Size & Forecast
    • 1.5.1 Global Human Thrombin for Extemal Use (Freeze-dried) Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity (2021-2032)
    • 1.5.3 Global Human Thrombin for Extemal Use (Freeze-dried) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Baxter
    • 2.1.1 Baxter Details
    • 2.1.2 Baxter Major Business
    • 2.1.3 Baxter Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.1.4 Baxter Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Baxter Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.2.4 CSL Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 VeraSeal
    • 2.3.1 VeraSeal Details
    • 2.3.2 VeraSeal Major Business
    • 2.3.3 VeraSeal Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.3.4 VeraSeal Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 VeraSeal Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.4.4 Octapharma Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 Kedrion
    • 2.5.1 Kedrion Details
    • 2.5.2 Kedrion Major Business
    • 2.5.3 Kedrion Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.5.4 Kedrion Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Kedrion Recent Developments/Updates
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.6.4 Pfizer Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pfizer Recent Developments/Updates
  • 2.7 Johnson & Johnson
    • 2.7.1 Johnson & Johnson Details
    • 2.7.2 Johnson & Johnson Major Business
    • 2.7.3 Johnson & Johnson Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.7.4 Johnson & Johnson Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Johnson & Johnson Recent Developments/Updates
  • 2.8 Cellphire, Inc.
    • 2.8.1 Cellphire, Inc. Details
    • 2.8.2 Cellphire, Inc. Major Business
    • 2.8.3 Cellphire, Inc. Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.8.4 Cellphire, Inc. Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cellphire, Inc. Recent Developments/Updates
  • 2.9 Hualanbio
    • 2.9.1 Hualanbio Details
    • 2.9.2 Hualanbio Major Business
    • 2.9.3 Hualanbio Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.9.4 Hualanbio Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hualanbio Recent Developments/Updates
  • 2.10 Zelgen
    • 2.10.1 Zelgen Details
    • 2.10.2 Zelgen Major Business
    • 2.10.3 Zelgen Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.10.4 Zelgen Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Zelgen Recent Developments/Updates
  • 2.11 Raas-corp
    • 2.11.1 Raas-corp Details
    • 2.11.2 Raas-corp Major Business
    • 2.11.3 Raas-corp Human Thrombin for Extemal Use (Freeze-dried) Product and Services
    • 2.11.4 Raas-corp Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Raas-corp Recent Developments/Updates

3 Competitive Environment: Human Thrombin for Extemal Use (Freeze-dried) by Manufacturer

  • 3.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Thrombin for Extemal Use (Freeze-dried) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Thrombin for Extemal Use (Freeze-dried) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Thrombin for Extemal Use (Freeze-dried) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Thrombin for Extemal Use (Freeze-dried) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Thrombin for Extemal Use (Freeze-dried) Manufacturer Market Share in 2025
  • 3.5 Human Thrombin for Extemal Use (Freeze-dried) Market: Overall Company Footprint Analysis
    • 3.5.1 Human Thrombin for Extemal Use (Freeze-dried) Market: Region Footprint
    • 3.5.2 Human Thrombin for Extemal Use (Freeze-dried) Market: Company Product Type Footprint
    • 3.5.3 Human Thrombin for Extemal Use (Freeze-dried) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Thrombin for Extemal Use (Freeze-dried) Market Size by Region
    • 4.1.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Thrombin for Extemal Use (Freeze-dried) Average Price by Region (2021-2032)
  • 4.2 North America Human Thrombin for Extemal Use (Freeze-dried) Consumption Value (2021-2032)
  • 4.3 Europe Human Thrombin for Extemal Use (Freeze-dried) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Thrombin for Extemal Use (Freeze-dried) Consumption Value (2021-2032)
  • 4.5 South America Human Thrombin for Extemal Use (Freeze-dried) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Thrombin for Extemal Use (Freeze-dried) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Type (2021-2032)
  • 5.3 Global Human Thrombin for Extemal Use (Freeze-dried) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Application (2021-2032)
  • 6.3 Global Human Thrombin for Extemal Use (Freeze-dried) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country
    • 7.3.1 North America Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country
    • 8.3.1 Europe Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Thrombin for Extemal Use (Freeze-dried) Market Size by Region
    • 9.3.1 Asia-Pacific Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country
    • 10.3.1 South America Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Thrombin for Extemal Use (Freeze-dried) Market Size by Country
    • 11.3.1 Middle East & Africa Human Thrombin for Extemal Use (Freeze-dried) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Thrombin for Extemal Use (Freeze-dried) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Thrombin for Extemal Use (Freeze-dried) Market Drivers
  • 12.2 Human Thrombin for Extemal Use (Freeze-dried) Market Restraints
  • 12.3 Human Thrombin for Extemal Use (Freeze-dried) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Thrombin for Extemal Use (Freeze-dried) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Thrombin for Extemal Use (Freeze-dried)
  • 13.3 Human Thrombin for Extemal Use (Freeze-dried) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Thrombin for Extemal Use (Freeze-dried) Typical Distributors
  • 14.3 Human Thrombin for Extemal Use (Freeze-dried) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Thrombin for Extemal Use (Freeze-dried) market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Human Thrombin for Extemal Use (Freeze-dried) is a topical thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.
    This report is a detailed and comprehensive analysis for global Human Thrombin for Extemal Use (Freeze-dried) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Thrombin for Extemal Use (Freeze-dried) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Thrombin for Extemal Use (Freeze-dried) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Thrombin for Extemal Use (Freeze-dried) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Thrombin for Extemal Use (Freeze-dried) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Thrombin for Extemal Use (Freeze-dried)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Thrombin for Extemal Use (Freeze-dried) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, CSL, VeraSeal, Octapharma, Kedrion, Pfizer, Johnson & Johnson, Cellphire, Inc., Hualanbio, Zelgen, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Thrombin for Extemal Use (Freeze-dried) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    500IU
    1000IU
    2500IU
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Baxter
    CSL
    VeraSeal
    Octapharma
    Kedrion
    Pfizer
    Johnson & Johnson
    Cellphire, Inc.
    Hualanbio
    Zelgen
    Raas-corp
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Thrombin for Extemal Use (Freeze-dried) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Thrombin for Extemal Use (Freeze-dried), with price, sales quantity, revenue, and global market share of Human Thrombin for Extemal Use (Freeze-dried) from 2021 to 2026.
    Chapter 3, the Human Thrombin for Extemal Use (Freeze-dried) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Thrombin for Extemal Use (Freeze-dried) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Thrombin for Extemal Use (Freeze-dried) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Thrombin for Extemal Use (Freeze-dried).
    Chapter 14 and 15, to describe Human Thrombin for Extemal Use (Freeze-dried) sales channel, distributors, customers, research findings and conclusion.

    Buy now